AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype (Q45127732)

9 December 2017

AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype (English)

1 reference

9 December 2017

1 reference

Madoka Yoshimura

1

1 reference

9 December 2017

Miki Sakamoto

2

1 reference

9 December 2017

Madoka Ikemoto

3

1 reference

9 December 2017

Yasushi Mochizuki

4

1 reference

9 December 2017

Katsutoshi Yuasa

5

1 reference

9 December 2017

Yuko Miyagoe-Suzuki

6

1 reference

9 December 2017

Shin'ichi Takeda

7

1 reference

9 December 2017

1 November 2004

1 reference

9 December 2017

1 reference

9 December 2017

10

1 reference

9 December 2017

821-828

1 reference

9 December 2017

5

1 reference

Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Recombinant adeno-associated virus for muscle directed gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Characterisation of dystrophin in carriers of Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Functional improvement of dystrophic muscle by myostatin blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Canine X-linked muscular dystrophy in Japan (CXMDJ)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Alpha1-syntrophin-deficient skeletal muscle exhibits hypertrophy and aberrant formation of neuromuscular junctions during regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2004.07.025

1 reference

9 December 2017

1 reference